usp-797-sterile-compounding-compliance-guide

Executive summary

Sterile compounding is a quality system—not a single checklist.

USP General Chapter <797> establishes minimum standards for compounding sterile preparations. Patient safety relies on more than a clean bench: the facility must integrate personnel competence, qualified air systems, aseptic technique, cleaning and disinfection, monitoring, documentation, storage and quality oversight. A sterile product can be compromised by an inappropriate touch, a damaged glove, inadequate airflow, unsuitable supplies or an uncontrolled process change.

The reason behind the standard

What patient safety gains from disciplined contamination control.

For patients receiving injections, infusions, ophthalmic preparations and other compounded sterile medicines, contamination can cause serious harm. USP <797> addresses risk arising during the preparation of CSPs. Each control is meaningful because it addresses a distinct failure mode; none is replaced by a supplier’s claim that a wipe or glove is “ISO 5 compatible.”

Determine applicability first

Compounding, approved-label preparation, immediate-use and hazardous-drug work are different.

The chapter covers people and settings that prepare compounded sterile preparations, including healthcare institutions, pharmacies and other covered clinical settings. The applicability assessment is important: not every manipulation of a sterile product is the same as sterile compounding. Distinguish compounding, administration and preparation according to approved labeling before applying a CSP category.

Use the USP <797> FAQ: scope and immediate-use to distinguish these workflows. A local policy can be stricter than a chapter minimum; the applicable jurisdiction can also affect how a chapter is enforced.

Core compliance distinction

Category 1, Category 2 and Category 3 require different operating evidence.

The revised chapter uses Category 1, Category 2 and Category 3, rather than the older low-, medium- and high-risk labels. The categories are distinguished primarily by preparation conditions, allowable dating and additional quality controls—not by a simple statement that one pharmacy is “safe” and another is “unsafe.” Category 3 is a distinct pathway that the prior SOSCleanroom page did not explain adequately.

Designated accountability

A documented quality system connects procedures, decisions and evidence.

A designated person (or persons) is responsible and accountable for oversight of the facility and its sterile-compounding personnel and practices. A credible program must make clear who can approve products, which quality evidence is reviewed, how deviations trigger action and who can stop or restart a process.

A good inspection drill traces a finished CSP backwards through personnel, equipment, drug component records, facility status and time-specific execution—not merely the presence of an SOP binder.

Engineering controls

The PEC protects exposed sterile materials only when the whole workflow supports it.

An ISO Class 5 primary engineering control (PEC) establishes a critical work zone for aseptic manipulations. It may be a laminar airflow workbench (LAFW), a suitable Class II or III biological safety cabinet (BSC), a compounding aseptic isolator (CAI) or a compounding aseptic containment isolator (CACI), where appropriate and qualified. The supporting room or SCA must match the CSP pathway and its requirements.

The USP FAQ sections on facility design and certification explain that independent certification is required before using a compounding area and that facility design and operating conditions affect testing.

Facility workflow

Airflow, clean boundaries and transfer pathways operate as one system.

Maintain clear separation of receiving, storage, gowning, material wipe-down, compounding and waste handling. In cleanroom suites, qualified airflow and pressure relationships support the desired direction of clean-to-less-clean air movement. Monitor conditions against established limits and address door-opening behavior, high-traffic transitions and material transfers.

Personnel hygiene and garbing

The sterile hand-to-product interface must be qualified and maintained.

People are major contributors to microbial contamination. Gowning is therefore a reproducible process—not merely a set of garments. Ensure personnel meet the chapter’s personal hygiene and garbing requirements for their assigned role and facility. Sterile gloves and proper gloved-hand disinfection are central to sterile operations.

Training and qualification

Demonstrate competence with evidence from real hands-on evaluations.

Personnel qualification should demonstrate observed ability to maintain aseptic technique, not simply completion of annual reading. Role-specific expectations differ for compounding personnel, people supervising compounding, and personnel entering to clean or restock the facility. A training matrix should state which activities each individual is qualified to perform and when reassessment is due.

The USP FAQ describes three successive, separately performed initial garbing competency evaluations, and explains how the gloved fingertip/thumb and media-fill tests are used and documented. Do not confuse GFT performed after donning with the separate GFT performed following media-fill testing. USP personnel qualification FAQs.

Protect exposed critical sites

Aseptic technique and qualified first air are inseparable.

Aseptic manipulation protects exposed critical sites: needle tips, syringe tips, vial septa, stopper penetrations and other surfaces that must remain microbiologically controlled. Operators must understand first air and avoid unnecessary motions or materials that disrupt the PEC’s qualified airflow. Technique must be assessed in representative work, including difficult or prolonged activities.

Materials and transfer

Protect the pathway from the shipping carton to the critical zone.

The exterior of a package may be unsuitable to introduce directly into the PEC, even if the contents are sterile. Evaluate the entire transfer pathway: receiving, removal of shipping packaging, surface treatment, access through the ante/buffer areas, and final presentation in the ISO Class 5 zone.

For example, Texwipe TX3213 sterile PolySat 70% IPA wipes and Texwipe TX3285 sterile AlphaSat10 polyester 70% IPA wipes offer different sterile pre-wetted formats; qualification depends on wetting, lint/particle performance, actual transfer requirements and pack handling.

Daily execution schedule

Map surfaces, chemicals, intervals and records before compounding starts.

Facilities should use the official chapter’s cleaning-and-disinfection frequency table and document site-specific schedules. The matrix below is an operational planning summary; it does not replace the complete Table 10, qualifiers or other applicable jurisdictional rules. Frequencies can become more stringent for Category 3, observed contamination and local SOP requirements.

Cleaning chemistries

Understand which agent performs which microbiological or cleaning task.

Cleaning physically removes soils and residues. Disinfection inactivates susceptible microorganisms according to a product’s validated claims and conditions. Sporicidal treatment addresses resistant spores. Sterile 70% IPA has a distinct place in the USP workflow; it is not a universal one-step cleaner or a sporicide.

Critical sterile alcohol practice

Use sterile 70% IPA correctly; do not treat every alcohol product as interchangeable.

Sterile 70% isopropyl alcohol is a defined element of sterile compounding, but it needs correct application technique. When used on gloved hands or surfaces, the SOP should cover compatible glove/substrate materials, contact/dry-down, wetness, controlled storage, opening/expiration and avoiding contamination of the dispenser.

Sterile IPA examples include TX3270 16 oz sterile 70% IPA and TX3273 32 oz sterile 70% IPA. Sterile ethanol products, such as TX3267 sterile 70% denatured ethanol, are distinct chemistries and must not be silently substituted where the chapter or facility SOP specifically requires sterile 70% IPA.

Low-lint cleaning tools

Select sterile wipes by substrate, test evidence, wetness and presentation.

Wiper selection can affect particulate release, chemical carryover, liquid absorbency, handling and sterile presentation. “Low lint” is not the same as “lint free.” A substrate should be evaluated against the actual operation, especially when it enters a PEC or contacts equipment near exposed critical sites.

Supplier qualification should request test methods and units for particles, fibers, ionic extractables and nonvolatile residues when process risk warrants. A marketing “ISO-class” label on a wipe is not product sterility certification and does not validate any particular aseptic task.

Room and equipment cleaning

Mops, covers, handles and zone segregation must support the facility program.

A cleaning procedure must include tool selection as well as chemistry. Mop covers, sponges and other contact materials used in a PEC require the appropriate sterile and low-lint status; handles and holders are a separate exception that must be cleaned and disinfected before use in the PEC. For rooms outside the PEC, control the appropriate nonsterile/sterile choices according to the chapter and site policy.

Browse SOSCleanroom cleanroom mops, sterile pre-wetted wipers and sterile 70% IPA solutions to plan a compatible cleaning system.

Barrier integrity

Gloves, gown cuffs and touch behaviors protect the exposed sterile process.

Sterile powder-free gloves serve as a patient/product barrier. They are a different decision from chemical resistance, ergonomics, particle cleanliness and chemotherapy-drug protection. Cuff placement, glove disinfection, handling after contact and changes must be trained as one procedure.

For sterile hazardous drugs, USP <800> requires additional appropriate chemotherapy-glove protection. Do not assume one sterile exam glove satisfies the two-pair hazardous-drug compounding requirement. See our technical glove selection guide and glove fit and sizing.

Microbial and particulate assurance

Environmental monitoring is a trend-and-response system, not a pass/fail sticker.

Environmental monitoring gives evidence that controlled spaces are performing under representative operating conditions. Nonviable particulate classification and viable microbiological monitoring answer different questions; neither alone proves a CSP is sterile. The sampling map must reflect facility risk, classified zones, activity and process flow.

The chapter and USP FAQ distinguish Category 1/2 monitoring from the more frequent Category 3 program. For example, the FAQ describes monthly pass-through surface sampling for Category 1/2 and at least weekly for Category 3. Implement the full official air/surface-monitoring schedules and action levels, rather than assuming those frequencies apply to every sample type. USP environmental monitoring FAQs.

Facilities and preventive maintenance

Certification must reflect the actual operating environment.

Independent facility and PEC certification must be performed before sterile compounding operations begin and thereafter at the required intervals or after events that affect performance. Use qualified personnel, acceptable procedures, documented limits and a formal return-to-service assessment following changes.

The BUD decision

The CSP category does not, by itself, authorize an expiration or beyond-use date.

Beyond-use dating (BUD) is not synonymous with expiration dating. A compounded sterile preparation’s allowable BUD depends on the applicable category and compounded preparation, ingredients, sterility assurance path, testing and storage conditions. Stability may require a shorter interval than any microbiological upper limit.

Where sterile and hazardous overlap

USP <797> does not replace the additional hazardous-drug requirements of USP <800>.

Sterile hazardous-drug compounding is subject to both USP <797> aseptic standards and USP <800> worker/environmental safeguards. Managing one hazard does not automatically manage the other. In particular, a chemotherapy-resistant glove may not be sterile and a sterile glove may not provide adequate hazardous-drug permeation protection.

Explore SOSCleanroom USP <800> Hazardous Drug Handling and the January 2026 USP <800> FAQs.

Recordkeeping and traceability

Audit readiness means your evidence tells one coherent story.

An inspector or quality reviewer should be able to reconstruct what happened, not simply confirm a daily log is signed. Document why the facility was suitable, who performed the work, what supplies were used and whether any unexpected conditions affected product quality.

Investigations and corrective action

A compliance program is measured by how well it responds when controls fail.

A positive microbiological result, failed gloved fingertip sample, certification problem, torn glove or missed disinfectant step requires a documented evaluation—not a generic “cleaned and closed” statement. The facility’s quality system should determine immediate containment, affected CSP assessment, root cause, corrective actions and verification that the process is again suitable.

Verified SOSCleanroom catalog

Connect each requirement to the right product—and the right evidence.

These products are verified SOSCleanroom catalog examples for technical evaluation, not a USP endorsement or a claim that one product makes a facility compliant. Confirm the exact model, SKU, sterile presentation, current technical documentation, packaging, chemistry and intended operation before approval. Product availability and pack units can change.

Browse by need: sterile solutions | sterile pre-wetted wipes | sterile products | cleanroom mops.

Purchasing and supplier control

Build a qualification file that survives both a substitution and an inspection.

Procurement should communicate the application and critical attributes, not just a competitor’s model number. For regulated facilities, an alternate product may require risk assessment, documentation, fit testing, procedural changes or validation before use.

Staff education

Apply the controls to common pharmacy situations before a deviation occurs.

Use these examples for technician onboarding, SOP review and management walk-throughs. They illustrate application of controls rather than prescribing an unapproved sterile-compounding method.

Self-assessment and inspection prep

Seventeen practical control checks for a document-ready sterile compounding program.

Use this as a supplemental, printable self-assessment. It is intentionally different from a regulatory inspection form: it helps assign tasks and evidence owners while requiring the responsible team to verify specific obligations against the official chapter. A checked item is not proof of compliance unless supported by current records.

The earlier SOSCleanroom condensed printable USP 797 checklist (January 2026) remains available as a brief reference. The expanded checklist above covers additional areas and should not be mistaken for an identical PDF edition.

Frequently asked questions

Direct answers for technicians, pharmacy leadership, facilities and buyers.

Continue learning

Connect sterile compounding to the wider SOSCleanroom Technical Vault.

Sources and review scope

Authoritative references for chapter-specific verification.

These primary and supporting sources are presented for technical checking. Some full standards require subscription or license. Manufacturer web listings support product attributes but not claims that a facility or process complies with USP requirements.

Editorial review: October 28, 2026. Refer to the current official licensed standards, manufacturer technical data and state board requirements before implementing changes; this article does not purport to reproduce or license USP text.

SOSCLEANROOM  |  STERILE COMPOUNDING SUPPLY SUPPORT

Build a More Consistent Sterile Compounding Supply Program.

Share your areas and work steps, sterile/nonsterile requirements, required chemistry, approved wiper and glove SKUs, packaging, annual consumption and documentation needs. SOSCleanroom can help identify candidate products and purchasing continuity options, while your responsible pharmacist, engineering and quality personnel retain responsibility for qualification and compliance.

Need assistance? 800-443-7101